CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients

Shinichi MaedaDing Qiang; HiroyukiShinchi; HiroshiKurahara; YukoMataki; HiroshiKurahara; KouseiMaemura; ShojiNatsugoe; SonshinTakao

首页> 外文期刊>The Open Surgical Oncology Journal >CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients

【24h】

CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients

机译：原发性肿瘤细胞中CD44和CD133的表达与胰腺癌患者的生存相关

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Open Surgical Oncology Journal》 |2009年第1期|共7页
作者
Shinichi MaedaDing Qiang; HiroyukiShinchi; HiroshiKurahara; YukoMataki; HiroshiKurahara; KouseiMaemura; ShojiNatsugoe; SonshinTakao;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer [J] . WakamatsuY., SakamotoN., OoH.Z., Pathology International . 2012,第2期

机译：癌干细胞标志物ALDH1，CD44和CD133在胃癌原发灶和淋巴结转移中的表达
2. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data [J] . Bahnassy Abeer A., Fawzy Mohamed, El-Wakil Mohamed, Translational research: the journal of laboratory and clinical medicine . 2015,第3期

机译：癌症干细胞标志物（CD44，CD90和CD133）的异常表达有助于肝母细胞瘤患者的疾病进展并降低生存率：4年生存数据
3. Influence of CD133+expression on patients' survival and resistance of CD133+cells to anti-tumor reagents in gastric cancer [J] . De-Hu Chen, Rui-Qi Lu, Xiao-Chun Ni, 亚太热带生物医学杂志（英文版） . 2015,第012期

机译：CD133 +表达对胃癌患者生存及CD133 +细胞抗肿瘤药耐药性的影响
4. A Pilot Study of Expression and Clinical Significance of Stem Cell-Like Markers CD133 or CD24 in Different Subpopulations of Gastric Cancer Circulating Tumor Cells [C] . Shiyang Wu, Suyan Liu, Yan Dong, International Molecular Medicine Tri-Conference. . 2016

机译：干细胞样标志物CD133或CD24在胃癌循环肿瘤细胞不同亚群中的表达及临床意义的试验研究
5. APE1/Ref-1 Redox Signaling Regulates HIF1a-Mediated CA9 Expression in Hypoxic Pancreatic Cancer Cells: Combination Treatment in Patient-Derived Pancreatic Tumor Models [D] . Logsdon, Derek Paul. 2018

机译：APE1 / Ref-1氧化还原信号调节低氧胰腺癌细胞中HIF1a介导的CA9表达：患者源性胰腺肿瘤模型的联合治疗
6. Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models [O] . Qihong Zhao, Heng Zhou, Qifei Liu, 2016

机译：癌干细胞相关标志物CD133和CD44表达在肝细胞癌中的预后价值：从患者到患者源性肿瘤异种移植模型
7. Table 8.4.c.1 Infiltration of cancer cells at pancreatic cut end margin (PCM) Table 8.4.c.2 Procedure of pancreatectomy and PCM Table 8.4.c.3 Infiltration of cancer cells at bile duct cut end margin (BCM) Table 8.4.c.4 Infiltration of cancer cells at dissected pancreatic tissue margin (DPM) Table 8.4.c.5 Procedure of pancreatectomy and DPM Table 8.4.c.6 Residual tumor Table 8.4.c.7 Procedure of pancreatectomy and residual tumor Figure 8.4.c.8 Survival of patients with endocrine tumor after pancreatectomy according to the infiltration of cancer cells at pancreatic cut end margin (PCM) Figure 8.4.c.9 Survival of patients with endocrine tumor after pancreatectomy according to the infiltration of cancer cells at dissected pancreatic tissue margin (DPM) Figure 8.4.c.10 Survival of patients with endocrine tumor after pancreatectomy according to the residual tumor [O] . 2007

机译：表8.4.C.1胰腺切割端缘（PCM）癌细胞的浸润表8.4.C.2胰腺切除术和PCM的程序表8.4.C.3胆汁管道切口癌细胞浸润边缘（BCM）表8.4.c.4在解剖胰腺组织边缘（DPM）下癌细胞浸润表8.4.c.5胰腺切除术和DPM的程序表8.4.c.6残留的肿瘤表8.4 .c.7胰腺切除术和残留肿瘤的程序图8.4.c.8根据胰蛋白酶切除末端边缘（PCM）的癌细胞渗透后，胰腺切除术后的患者存活患者图8.4.c.9根据残留胰腺组织边缘的癌细胞渗透（DPM）渗透后，胰腺切除术后的患者存活患者图8.4.c.10根据残留肿瘤，胰腺切除术后的内分泌肿瘤患者存活

CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients

著录项

相似文献

相关主题

期刊订阅